One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1182/blood-2018-99-114502
Copy DOI Journal: Blood |  Publication Date: Nov 29, 2018 |
 Citations: 11 |
Affiliation: Emory University, Princess Margaret Cancer Centre, University of Toronto, University Hospital Cologne, Mayo Clinic, Memorial Sloan Kettering Cancer Center, The University of Texas MD Anderson Cancer Center, General University Hospital in Prague, Karmanos Cancer Institute, Churchill Hospital, University of Bologna, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Dana-Farber Cancer Institute, Humanitas University, Los Angeles Medical Center, Bristol-Myers Squibb (United States)Nivolumab Treatment Beyond Investigator-Assessed Progression: Extended Follow-up in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma from the Phase 2 CheckMate 205 Study
Sign-in/Register to access full text options 
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
